Stableford Capital II LLC Cuts Stock Holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Stableford Capital II LLC cut its position in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 40.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,144 shares of the company’s stock after selling 16,958 shares during the period. Stableford Capital II LLC owned 0.09% of Establishment Labs worth $1,001,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ESTA. Hood River Capital Management LLC purchased a new position in shares of Establishment Labs in the second quarter worth about $43,000. Nkcfo LLC acquired a new position in shares of Establishment Labs during the 2nd quarter worth approximately $227,000. Concurrent Investment Advisors LLC purchased a new stake in shares of Establishment Labs in the first quarter valued at approximately $263,000. SG Americas Securities LLC acquired a new stake in shares of Establishment Labs in the second quarter valued at approximately $303,000. Finally, Bay Colony Advisory Group Inc d b a Bay Colony Advisors purchased a new position in Establishment Labs during the second quarter worth approximately $373,000. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. dropped their price objective on shares of Establishment Labs from $61.00 to $50.00 and set an “overweight” rating for the company in a report on Wednesday, August 7th. BTIG Research upped their price objective on Establishment Labs from $62.00 to $65.00 and gave the company a “buy” rating in a report on Monday. Citigroup raised their target price on Establishment Labs from $45.00 to $50.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 1st. Finally, Stephens reaffirmed an “overweight” rating and issued a $68.00 price target on shares of Establishment Labs in a research note on Wednesday, August 7th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $58.83.

Establishment Labs Stock Performance

NASDAQ:ESTA opened at $42.53 on Wednesday. The stock has a market capitalization of $1.17 billion, a P/E ratio of -13.54 and a beta of 1.20. The company has a debt-to-equity ratio of 4.30, a quick ratio of 2.91 and a current ratio of 4.44. Establishment Labs Holdings Inc. has a fifty-two week low of $16.96 and a fifty-two week high of $60.12. The company has a 50 day moving average price of $42.71 and a 200 day moving average price of $46.69.

Establishment Labs (NASDAQ:ESTA) last issued its quarterly earnings data on Tuesday, August 6th. The company reported ($0.62) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.51) by ($0.11). Establishment Labs had a negative net margin of 54.97% and a negative return on equity of 220.67%. The firm had revenue of $44.12 million during the quarter, compared to analyst estimates of $43.10 million. During the same period in the previous year, the firm posted ($0.65) earnings per share. The company’s quarterly revenue was down 9.2% compared to the same quarter last year. Equities research analysts forecast that Establishment Labs Holdings Inc. will post -2.27 EPS for the current year.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.